Clinical Trials List
2012-10-01 - 2017-12-31
Phase II/III
Terminated3
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chiun Hsu Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chi Chou Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Tse-Ching Chen Division of Others -
- Tsai-Sheng Yang Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- 曾振輝 Division of Radiology
- Hung-Chih Hsu Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
412 participants
